These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12552979

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue.
    Bilgrami S, Chakraborty NG, Rodriguez-Pinero F, Khan AM, Feingold JM, Bona RD, Edwards RL, Dorsky D, Clive J, Mukherji B, Tutschka PJ.
    Bone Marrow Transplant; 1999 Mar; 23(5):469-74. PubMed ID: 10100561
    [Abstract] [Full Text] [Related]

  • 3. Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.
    Svane IM, Nikolajsen K, Hansen SW, Kamby C, Nielsen DL, Johnsen HE.
    Bone Marrow Transplant; 2002 Apr; 29(8):659-66. PubMed ID: 12180110
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation.
    Fagnoni FF, Lozza L, Zibera C, Zambelli A, Gibelli N, Oliviero B, Ponchio L, Fregoni V, Pavesi L, Perotti C, Da Prada G, Robustelli della Cuna G.
    Bone Marrow Transplant; 2003 Jan; 31(1):31-8. PubMed ID: 12621504
    [Abstract] [Full Text] [Related]

  • 5. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E, Schnürer E, Wagner E, von Auer C, Plachter B, Wehler D, Huber C, Kolbe K, Meyer RG, Herr W.
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of amifostine on reconstitution of lymphocyte subpopulations after conventional- and high-dose chemotherapy in patients with germ cell tumor.
    Rick O, Beyer J, Schwella N, Siegert W.
    Ann Hematol; 2002 Dec; 81(12):717-22. PubMed ID: 12483368
    [Abstract] [Full Text] [Related]

  • 11. Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer.
    Chandrasekar PH, Abraham OC, Klein J, Alangaden G, Chalasani G, Cassells L, Dansey R, Abella S, Karanes C, Peters W, Baynes R.
    Clin Infect Dis; 2001 Feb 15; 32(4):546-51. PubMed ID: 11181116
    [Abstract] [Full Text] [Related]

  • 12. Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
    Kohno K, Nagafuji K, Tsukamoto H, Horiuchi T, Takase K, Aoki K, Henzan H, Kamezaki K, Takenaka K, Miyamoto T, Teshima T, Harada M, Akashi K.
    Transpl Infect Dis; 2009 Aug 15; 11(4):318-23. PubMed ID: 19453993
    [Abstract] [Full Text] [Related]

  • 13. Peripheral progenitor cells (PBPC) in supportive care after high-dose chemotherapy in breast cancer.
    Filip S, Bláha M, Petera J, Vavrová J, Knízek J.
    Neoplasma; 2001 Aug 15; 48(1):39-47. PubMed ID: 11327536
    [Abstract] [Full Text] [Related]

  • 14. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
    Han XH, Shi YK, He XH, Yang JL, Liu P.
    Zhonghua Zhong Liu Za Zhi; 2003 Jan 15; 25(1):47-50. PubMed ID: 12678987
    [Abstract] [Full Text] [Related]

  • 15. Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation.
    Larosa F, Marmier C, Robinet E, Ferrand C, Saas P, Deconinck E, Bulabois CE, Rohrlich PS, Ledu K, Helias P, Tiberghien P, Cahn JY.
    Bone Marrow Transplant; 2005 May 15; 35(9):859-68. PubMed ID: 15765116
    [Abstract] [Full Text] [Related]

  • 16. Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT).
    Reimer P, Kunzmann V, Wilhelm M, Weissbrich B, Kraemer D, Berghammer H, Weissinger F.
    Ann Hematol; 2003 May 15; 82(5):263-70. PubMed ID: 12739062
    [Abstract] [Full Text] [Related]

  • 17. Influence of total body irradiation on infections after autologous bone marrow transplantation.
    Callum JL, Brandwein JM, Sutcliffe SB, Scott JG, Keating A.
    Bone Marrow Transplant; 1991 Oct 15; 8(4):245-51. PubMed ID: 1756321
    [Abstract] [Full Text] [Related]

  • 18. Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
    Stemmler HJ, Salat C, Lindhofer H, Menzel H, Untch M, Kahlert S, Konecny G, Sauer H, Ledderose G, Heinemann V, Kolb HJ.
    Anticancer Res; 2005 Oct 15; 25(4):3047-54. PubMed ID: 16080564
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation.
    Offidani M, Corvatta L, Olivieri A, Mele A, Brunori M, Montanari M, Rupoli S, Scalari P, Leoni P.
    Clin Infect Dis; 2001 May 15; 32(10):1414-22. PubMed ID: 11317241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.